Cartesian Therapeutics
RNAC
#6732
Rank
A$0.71 B
Marketcap
$29.85
Share price
3.61%
Change (1 day)
-41.09%
Change (1 year)

Cartesian Therapeutics (RNAC) Fails to deliver data

Key failure to deliver metrics for Cartesian Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Cartesian Therapeutics (RNAC) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Cartesian Therapeutics (RNAC) - since 2016

Volume in USD (price x number of shares), data since 2016

Cartesian Therapeutics (RNAC) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$0.52 M-58.7%
2023A$1.26 M35.2%
2022A$0.93 M-65.65%
2021A$2.71 M-98.97%
2020A$0.26 B19268.73%
2019A$1.36 M-89.59%
2018A$13.06 M194.21%
2017A$4.44 M-48.1%
2016A$8.55 M